CRSP
CRISPR Therapeutics AG
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com.
Market Cap: 6.49 Billion
Primary Exchange: NASDAQ
Website: www.crisprtx.com
Shares Outstanding: 80.3 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.0
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Ethical Flags
Longest drawdown: 1370 trading days
From: 2018-05-30 To: 2020-06-22
Lowest Point:
Crispr: Vertex Doubled Down On The Reigning Champion CRISPR/Cas9
via: SeekingAlpha at 2019-06-11 10:39:27:000
All there is to investing is picking good stocks at good times and staying with them as long as they remain good companies. - Warren Buffett If you look at a fruitful marriage, chances are that the house is filled with joy and laughter. In bioscience investment, the pursuit of happiness al… read more...
Crispr: Vertex Doubled Down On The Reigning Champion CRISPR/Cas9
via: SeekingAlpha at 2019-06-11 10:39:27:000
All there is to investing is picking good stocks at good times and staying with them as long as they remain good companies. - Warren Buffett If you look at a fruitful marriage, chances are that the house is filled with joy and laughter. In bioscience investment, the pursuit of happiness al… read more...
Crispr: Vertex Doubled Down On The Reigning Champion CRISPR/Cas9
via: SeekingAlpha at 2019-06-11 10:39:27:000
All there is to investing is picking good stocks at good times and staying with them as long as they remain good companies. - Warren Buffett If you look at a fruitful marriage, chances are that the house is filled with joy and laughter. In bioscience investment, the pursuit of happiness al… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|